Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$53.58 0.50 (0.94%)
2/9/2010 4:01 PM

Novartis AG (ADR) (NVS)

CAPS Rating:
****

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating NVS

Add Stock to Watchlist

What the Community Thinks

Total Members

1374 Outperforms
49 Underperforms
 

All-Stars

505 Outperforms
14 Underperforms
 

Wall Street

16 Outperforms
3 Underperforms
 

Members bullish on NVS are also bullish on:

Members bearish on NVS are also bearish on:

Ticker Tags

Mega Cap (110), Big Pharma (10), Top Brands 2005 (58), Pharmaceuticals (149), Defensive (1457), Dividend (191), Income (1401), Top Brands 2006 (59), Healthcare (711), Switzerland (8), Growth (1902), International Stock (684), Bird Flu (7)
Suggest a tag

Novartis AG (ADR) At A Glance

Current Price: $53.58
Last Trade Time: 2/9/2010 4:01 PM
Open: $53.23
Previous Close: $53.08
Daily Range: $53.06 - $53.79
52-Week Range: $33.34 - $56.42
Volume: 2,507,700
Market Cap: $121.86B
P/E Ratio: 14.35
Compare Our Special Broker Offers!

Stock Trends

NVS VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for NVS

More Headlines...

Top Bull Pitch

Recs

1

Novartis AG (ADR) (NVS)

Avatar TSIF (98.89) Submitted: 10/12/09 11:45 AM

It's hard to be blue about a stock that's up 32%, but picking Novartis to outperform the S&P back in Feb. isn't working out so well on CAPS with the S&P up 40%! I still like the call, (and in your portfolio you don't have to beat the S&P!). With margins in the 20% range and annual rev...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Novartis AG (ADR) (NVS)

Avatar nipous (22.17) Submitted: 8/05/08 4:29 PM

After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of months while NVS hangs around somewhat.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 194 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (NVS)

Avatar buschydaddy (< 20) Submitted: 2/09/10 12:04 PM : Outperform Start Price: $53.56 NVS Score: 0.51

Oncology pipeline looks good.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVS)

Avatar rainman70 (81.12) Submitted: 2/09/10 12:14 AM : Outperform Start Price: $53.23 NVS Score: 0.57

Forward PE of 10.5. Great innovations in diabetes disease management. Diabetes is not only affecting many younger Americans, but the Baby Boomer generation is moving into a high risk group. 3.2% dividend yield. This is an expensive stock, but I think equities are facing a tough year ahead, and NVS provides above average shelter from the storms ahead.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVS)

Avatar tonyrjohnson (29.91) Submitted: 1/28/10 6:52 AM : Outperform Start Price: $53.87 NVS Score: 2.17

Turnaround, acquisition and good pipeline

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVS)

Avatar malcarada (45.12) Submitted: 11/20/09 8:31 PM : Outperform Start Price: $54.66 NVS Score: 1.19

Drugs company well positioned to benefit from the flu pandemic and the universal health care provisions.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVS)

Avatar emptygestures (33.88) Submitted: 11/19/09 2:12 PM : Outperform Start Price: $53.13 NVS Score: 2.85

I bought this one back in April and am very satisfied with the growth. This one is a long term investment with a strong reputation in the biotech industry.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 194 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 19 of 19  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackDeutscheSec 89.68 11/17/09 Outperform NS $53.88-0.56%-2.86%+2.31
TrackBarclaysCap 94.50 11/13/09 Underperform NS $53.14+0.83%-2.53%-3.36
TrackCitigroup 85.92 10/01/09 Outperform NS $50.21+6.71%+0.81%+5.90
TrackJefferies 82.08 09/16/09 Outperform NS $47.72+12.28%+2.16%+10.12
TrackJPMorgan 84.76 07/17/09 Outperform NS $42.47+26.16%+14.54%+11.62
TrackJimCramer < 20 05/08/09 Underperform 3W $38.36+39.68%+16.52%-23.16
TrackCowenandCo 86.76 06/04/08 Outperform NS $50.78+5.52%-19.36%+24.87
TrackBernstein 87.54 05/09/08 Outperform NS $49.09+9.14%-19.66%+28.80
TrackHSBC 86.09 02/29/08 Underperform NS $48.27+11.01%-17.60%-28.61
TrackTobinSmith < 20 01/25/08 Outperform 1Y $47.00+14.00%-16.01%+30.01
TrackPatDorsey 92.89 11/09/07 Outperform 5Y $48.74+9.93%-22.60%+32.53
TrackEdwardOwens 98.91 09/30/07 Outperform NS $51.41+4.21%-26.38%+30.59 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $51.41+4.21%-26.38%+30.59 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 93.31 09/30/07 Outperform NS $51.41+4.21%-26.38%+30.59 Toggle the visibility of 60-Second Pitch and replies
TrackJohnKeeley < 20 09/30/07 Outperform NS $51.41+4.21%-26.38%+30.59 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 90.73 09/30/07 Outperform NS $51.41+4.21%-26.38%+30.59 Toggle the visibility of 60-Second Pitch and replies
TrackUBS 87.99 09/06/07 Outperform NS $49.94+7.30%-23.71%+31.01
TrackJimJubak 78.84 12/01/06 Outperform 1Y $53.08+0.94%-18.79%+19.74
TrackBofASec 94.61 09/11/06 Outperform NS $51.80+3.43%-11.98%+15.41

Results 1 - 19 of 19  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 625ms